These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 455272)

  • 1. Effect of L-alpha-amino-gamma-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemia.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 May; 6(6):345-50. PubMed ID: 455272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 Jan; 6(1):7-13. PubMed ID: 544013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.
    Vistica DT
    Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells.
    Vistica DT
    Blood; 1980 Sep; 56(3):427-9. PubMed ID: 7407411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of melphalan by sensitive and resistant L1210 cells.
    Redwood WR; Colvin M
    Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro.
    Martin AD; Beer RW; Bosanquet AG; Gilby ED
    Biochem Pharmacol; 1982 Sep; 31(17):2727-32. PubMed ID: 7138568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system.
    Vistica DT; Rabinovitz M
    Biochem Biophys Res Commun; 1979 Feb; 86(3):929-32. PubMed ID: 426830
    [No Abstract]   [Full Text] [Related]  

  • 11. Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
    Tobias JS; Parker LM; Tattersall MH; Frei E
    Br J Cancer; 1975 Aug; 32(2):199-207. PubMed ID: 1212350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature dependence and effect of membrane lipid alteration on melphalan transport in L1210 murine leukemia cells.
    Burns CP; Dudley DT
    Biochem Pharmacol; 1982 Jun; 31(11):2116-9. PubMed ID: 7115429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
    Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells.
    Vistica DT; Rabon A; Rabinovitz M
    Biochem Pharmacol; 1979 Nov; 28(21):3221-5. PubMed ID: 526327
    [No Abstract]   [Full Text] [Related]  

  • 18. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids.
    Vistica DT; Schuette BP
    Mol Pharmacol; 1981 Jan; 19(1):92-6. PubMed ID: 7207465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.